✦ LIBER ✦

Late consolidative radiation therapy in the treatment of limited-stage small cell lung cancer

✍ Scribed by Robert W. Carlson; Branimir I. Sikic; David R. Gandara; Charles G. Hendrickson; Peter S. Wittlinger; John A. Shields; Peter P. Wong; Joel E. White; Charles J. Meakin; Karen M. McWhirter; Kathleen R. Lamborn; Theodore L. Phillips

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 1005 KB
Volume: 68
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19910901)68:5<948::aid-cncr2820680507>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The results of treatment in 100 patients

The results of treatment in 100 patients with limited-stage small cell lung cancer

✍ Xuyi Liu; Xiaokui Li; Yubin Pang; Qingqi Li; Xueyi Wang; Wenjong Shen 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB 👁 2 views

## Background: In an attempt to improve treatment results of small cell lung cancer (sclc), combined induction chemotherapy and thoracic and prophylactic brain radiation therapy were administered. ## Method: From december 1980 to december 1987, 112 patients with limited-stage sclc were treated wi

Hypofractionated radiation therapy in un

Hypofractionated radiation therapy in unresectable stage iii non-small cell lung cancer

✍ B. J. Slotman; K. H. Njo; A. De Jonge; O. W. M. Meijer; A. B. M. F. Karim 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 769 KB

Results of combined-modality therapy for

Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly

✍ Steven E. Schild; Philip J. Stella; Burke J. Brooks; Sumithra Mandrekar; James A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twice‐daily radiotherapy (BIDRT) or once‐daily radiotherapy (QDRT) resulted in a better outcome for patients with limited‐st

Treatment of small cell lung cancer: Int

Treatment of small cell lung cancer: Intensive remission induction, radiation therapy, and maintenance chemotherapy

✍ Bezwoda, W. R. ;Derman, D. P. ;de Moor, N. G. ;Kallenbach, J. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB

## Abstract Forty‐eight patients with small cell lung cancer were treated with an intensive therapy regimen which included induction chemotherapy with vincristine, adriamycin, procarbazine, and methotrexate. This was followed by radiation therapy given to areas of residual disease after restaging.

Phase II study of neoadjuvant chemothera

Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer

✍ Margaret Deutsch; Jeffrey Crawford; Kenneth Leopold; Walter Wolfe; William Foste 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 939 KB

Prognostic significance of serum p53 ant

Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer

✍ Gérard Zalcman; Jean Trédaniel; Beata Schlichtholz; Thierry Urban; Bernard Mille 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 239 KB 👁 2 views

p53 tumour suppressor gene alterations are one of the most frequent genetic events in lung cancer. A subset of patients with p53 mutation and cancer exhibited circulating serum anti-p53 self-antibodies (p53-Ab). The prevalence of these antibodies in lung cancer is currently being analysed in a multi